Uncontrolled growth and abnormal cellular behaviour are traits of both cancer cells and autoimmune and inflammatory disorders. By creating medicines to block the growth and control the behaviour of these abnormal cells, we aim to make a real difference in the lives of patients and their families. We are advancing a growing pipeline of investigational medicines that will enhance the effectiveness of some of the most commonly used standard-of-care chemotherapies for cancer treatment and improve existing treatments for inflammatory conditions such as rheumatoid arthritis.